News

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

Melissa Magwire talks about why diabetes is a population health problem and a unique program at Saint Luke's that is helping patients across the nation.

KCTV talked to Melissa Magwire,RN, MSN, CDE, program director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence, to learn more about the Cardiometabolic Center.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.